Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

    brain
    Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Solutions
  3. Medical Imaging
  4. Imaging therapeutic expertise
  5. Oncology

Oncology

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Experts in the complex world of clinical trial oncology response criteria implementation

  • 992

    Clinical trials
  • 237,605

    Subjects
  • 59,195

    Sites

Oncology clinical trials face new challenges with the continued advent of novel therapeutic areas in targeted cancer therapies and personalised immunotherapy. This increases the pressure to deliver precise tumor phenotyping, staging and early outcome predictors in trials. These are key areas where medical imaging is proving to be a critical component for the timely delivery of endpoints in oncology trials.

ICON has a highly experienced Oncology imaging service that is underpinned by a robust team of specialists that have more than 650 Oncology imaging trials under their wing, contributing to over 21 approvals by the FDA.

We work with thousands of sites across the globe to provide support, image quality assessments, reconciliation, and post processing.

Our team of highly trained specialists include key opinion leaders in radiology and clinical oncology, medical imaging experts, oncology study coordinators, biomedical engineers, statisticians, and allied support personnel.

Our specialists have vast experience with a wide variety of cancers, their treatments, and their image assessment criteria. They have mastered imaging technologies including CT, MRI, PET-CT, Nuclear Medicine, and Ultrasound which ensures your requirements are met for the successful completion of your trial.

  • Indications include: Breast, Colorectal, Gastric, Glioblastoma, Glioma, Head and Neck, Lung, Lymphoma, Melanoma, Ovarian Prostate, Renal Cell
  • Criteria include:RECIST, mRECIST, Choi, RANO, Cheson, Lugano Classification, Halleck, iRECIST, RECIL, iRANO/bmRANO/pedRANO, PCWG, PCWG3

Delivering benefits to your oncology study:

 

 

- Access to over 700 highly trained radiologists

With experience in body imaging, PET imaging and Nuclear medicine.

- Integrated clinical and medical imaging service teams

That have direct lines of communication, facilitating and streamlining project management. We prioritise study timelines across clinical and imaging services during start-up to minimise time to first patient in (FPI), and after last patient out (LPO) to reduce time to database lock.

- A range of support resources

Including in-house scientific experts, data management specialists, medical writing and translation services.

- High quality training support

Provided to the CTM/CRA team which assists with overall knowledge, timely submission of imaging, and the importance of open lines of communication with key site contacts.

- Greater accountability and collaboration

Across service teams for early identification and mitigation of study risks, lower query rates, and prompt implementation of any required corrective and preventative actions.

Oncology imaging slipsheet for trials.

ICON Medical Imaging solutions for oncology studies

Transforming images into information. Turning information into therapies

Find out more:

Discover how ICON Medical Imaging can enhance your clinical trials

Contact us
In this section
In this section
  • Asset Development Consulting
    • Adaptive trials
    • Dose optimisation strategies
    • Due diligence and asset valuation
    • Nonclinical and pre clinical development
    • Novel statistical methods
    • Protocol optimisation
    • Target product profile
  • Blended Solutions
  • Cardiac Safety Solutions
  • Clinical & Scientific Operations
    • Accelerated study start-up
    • Biostatistics and Programming
    • Clinical Operations
      • Clinical Monitoring
        • Risk based monitoring
      • Trial Master File services
    • Data Monitoring Committee Services
    • Clinical Supplies Management
    • COVID-19
      • COVID-19 treatment and vaccine trials
    • Clinical data science
      • CDISC Data Standardisation
    • Endpoint Adjudication Services
    • Global Logistics
      • Depot and Distribution Services
      • Global Logistics factsheets
    • Interactive Response Technology
      • Help Desk Services
    • Investigator Payments
      • Tax Management and Contracting
      • The Need for Flexibility
    • Medical Affairs
    • Medical Call Centre Services
    • Medical Writing & Publishing
    • Pharmacovigilance
      • Tailored pharmacovigilance solutions for biotech and small to mid-sized companies
      • Affiliate Level Solution
      • Ensuring patient safety
      • Risk Management & REMS Solutions
      • Safety Reporting Group
      • Safety writing solutions
    • Project and Program Management
  • Commercial Positioning
    • Health Economics and Outcomes Research
    • Market Access
    • Market Research & Analytics
    • Global Medical and Commercial Agency
    • Medical & Value Communications
      • Creative & Digital Services
        • Awards
      • Publication Management
    • Patient Reported Outcomes
  • Decentralised Clinical Trials
    • In-Home Services
  • Early Clinical
    • Accelerated Pharmaceutical Solutions
    • Bioanalytical Laboratories
    • Biometrics
    • Clinical Pharmacology
    • Clinical Research Facilities
    • Early Phase Oncology
    • Ethnic Bridging Studies
    • Medical Affairs
    • Early Phase Patient Studies
    • Early Phase Obesity Trials
    • Quality and Compliance
    • TQT studies
    • Quantitative Pharmacology and Pharmacometrics
    • Volunteer Recruitment
  • Language Services
    • Clinical and Medical Translations
    • Linguistic Validation
    • Translation Technologies
  • Laboratories
    • Bioanalytical Laboratories
      • Applications
        • Pharmacokinetics
        • Biomarkers
        • Immunogenicty
        • ADCs
        • ADME
        • Metabolites
        • Oligonucleotides
      • Technologies
        • Flow Cytometry
        • LC-MS/MS
        • Ligand Binding Assays
        • qPCR
        • Liquid Scintillation Counting (LSC)
    • Central Laboratories
      • Laboratory Client Services
        • Site Support Services
      • Study Management Tools
      • Digital Pathology
      • Global Data Services
      • Logistical Tools
      • Integrated Clinical Research & Laboratory Services
      • iRIS: A Focus on Local Laboratory Results
      • Laboratory Facilities
      • Quality Assurance
      • Testing Capabilities
    • Specialty Biomarker Laboratories
      • Laboratory Facilities
        • Cambridge Specialty Lab
        • Portland Specialty Lab
      • Biomarker testing portfolio
        • Genomics
        • Histopathology/IHC
        • Multiplex Immunofluorescence
        • Flow Cytometry
        • Biomarker test menu
    • Biospecimen Services
    • Biotech Laboratory Solutions
  • Medical Imaging
    • Collect and hold
    • Imaging therapeutic expertise
      • Metabolic disease
        • Obesity weight loss
        • MASH/MASLD
      • Cardiovascular
      • Central Nervous System
      • Oncology
    • Rescue studies
    • Technology platforms
  • Outcome Measures
    • Clinical Outcome Assessments
    • Digital Health Technologies
    • eCOA Technology
  • Real World Intelligence
    • Clinical Trial Tokenisation
    • Real World Evidence and Late Phase Research
      • Remote Monitoring for Late Phase
    • RWE Strategy and Analytics
  • Regulatory Affairs
    • Global Clinical Trials
    • Regulatory Project Services
    • Global Regulatory Strategy
    • CMC & Quality Services
    • Regulatory Operations
    • Global Labelling & Ad Promotion
    • Medical Device and Diagnostics
    • Clinical Diagnostics Regulatory Affairs: IVD/CDx
  • Symphony Health data
    • Symphony Health Conference Posters
    • Health technology and business intelligence solutions
      • Metys®
    • Integrated Dataverse and Source Solutions
    • Optimise brand strategy and sales effectiveness
      • HealthRankings
    • Solve market access challenges
    • Understand the patient journey
    • Making Medicines More Affordable
  • Site & Patient Solutions
    • Patient Centred Services
      • Concierge Services
      • Patient Insights and Engagement
      • Patient Recruitment
      • Accellacare site resourcing
      • Site engagement
    • Site & patient obesity solutions
    • Sites
      • ICON’s Elite Sites Program
      • Global Site Network
  • Strategic Solutions
    • Careers in Strategic Solutions
    • Data-enabled FSP
    • Organisational design
    • Technology-led innovation
  • Technologies
    • AI at ICON
      • One Search
      • Cassandra
      • EngageAI
    • LabView360
    • CARD
    • Signet
    • ARCADES
    • FIRECREST
      • Site Portal
      • Learn
        • Training
        • Visit-by-Visit Guide
        • Medical Animation
        • Patient Education
      • Engage
        • Referral Management Console
        • Safety Letters
        • Site Question Management
        • Study News
        • Pre-Screen
        • Document Exchange and Tracking
    • ICON Digital Platform
    • OneView
    • ICON ORCA Safety
    • Evidence Platform
    • Control Tower
    • FLEX ADVANTAGE
    • Medical Imaging Technology
    • ICON ORCA Safety
    • NONMEM
      • NONMEM FAQs
    • Clinical Data Studio
    • PDx-POP
    • PubsHub
      • Journals & Congresses℠
      • Knowledge Manager℠
      • PMSolution℠
    • SIMS
    • ICOMaster for eTMF
    • Prism Connect
    • SmartDraft
    • HORIZON

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

Related information:

Whitepaper

Whitepaper: Advances in imaging biomarkers: Estimating drug efficacy with tumour growth rate modelling

Case studies

Case study: Phase 3 Multiple Myeloma study

Case studies

Case study: Phase 3 unresectable biliary tract carcinoma study

Webinar

Webinar: Advances in oncological imaging: Tumour growth rate modelling and radiomics

Therapeutics

Webpage: Oncology expertise

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence